Milestone Pharmaceuticals Inc

Milestone Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a prescription medication for converting acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. The company is also developing etripamil for atrial fibrillation with rapid ventricular rate (AFib-RVR). It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Incorporated in 2003, Milestone Pharmaceuticals Inc. is headquartered in Montreal, Canada.